We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Approves $65 Million Settlement in Paxil Antitrust Case
Court Approves $65 Million Settlement in Paxil Antitrust Case
May 3, 2005
A federal judge has approved a settlement agreement under which GlaxoSmithKline (GSK) will pay $65 million to settle a class-action antitrust lawsuit over its antidepressant Paxil.